• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alkermes plc - Ordinary Shares (NQ:ALKS)

28.35 -0.93 (-3.18%)
Streaming Delayed Price Updated: 4:00 PM EST, Mar 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,233,645
Open 29.00
Bid (Size) 28.00 (3,500)
Ask (Size) 29.50 (200)
Prev. Close 29.28
Today's Range 28.17 - 29.18
52wk Range 25.16 - 36.32
Shares Outstanding 166,121,384
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Alkermes (ALKS) Q4 2025 Earnings Call Transcript ↗
February 25, 2026
Alkermes (ALKS) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Alkermes PLC (NASDAQ:ALKS) Reports Strong Q4 Earnings Beat Amid Muted Market Reaction ↗
February 25, 2026
Via Chartmill
Topics Earnings

Performance

YTD
+0.3%
+0.3%
1 Month
-17.8%
-17.8%
3 Month
-3.2%
-3.2%
6 Month
-2.0%
-2.0%
1 Year
-19.6%
-19.6%

More News

Read More
News headline image
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2025 and Provides Financial Expectations for 2026
February 25, 2026
From Alkermes plc
Via Business Wire
News headline image
Alkermes plc Announces CEO Succession Plan
February 25, 2026
From Alkermes plc
Via Business Wire
Race For Avadel Heats Up: Alkermes Raises Offer To Secure $2.37B Deal After Lundbeck Challenge ↗
November 19, 2025
Via Stocktwits
News headline image
Earnings Scheduled For October 28, 2025 ↗
October 28, 2025
Via Benzinga
News headline image
Preview: Alkermes's Earnings ↗
October 27, 2025
Via Benzinga
News headline image
Alkermes to Present at the TD Cowen 46th Annual Health Care Conference
February 24, 2026
From Alkermes plc
Via Business Wire
News headline image
From Sizable Stake to Zero: The Likely Reason Why Agios Shares Lost a $94 Million Backer ↗
February 23, 2026
Via The Motley Fool
News headline image
Viridian Therapeutics Stock Up 75%, but One Fund Just Sold Off Its $69 Million Stake ↗
February 23, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Spyre Therapeutics Stock Surges This Past Year as $10.5 Million Buy Lifts Stake to $78 Million ↗
February 23, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Biotech Fund Dumps 1.85 Million Centessa Shares as Stock Jumps Over 50% ↗
February 23, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Biotech Fund Dumps $84 Million of Nuvalent With Stock Up 29% ↗
February 23, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market
February 12, 2026
From Alkermes plc
Via Business Wire
News headline image
Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026
February 11, 2026
From Alkermes plc
Via Business Wire
News headline image
Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1
January 06, 2026
From Alkermes plc
Via Business Wire
News headline image
Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 30, 2025
From Alkermes plc
Via Business Wire
News headline image
Alkermes to Participate in Two Upcoming Investor Conferences
November 25, 2025
From Alkermes plc
Via Business Wire
News headline image
Lundbeck's Higher Buyout Proposal Challenges Alkermes' Pending $2 Billion Avadel Deal ↗
November 14, 2025
Via Benzinga
News headline image
Avadel Surges 20% On Lundbeck's Surprise Alkermes-Topping Bid ↗
November 14, 2025
Via Investor's Business Daily
News headline image
Avadel Gets Acquisition Proposal From Lundbeck Weeks After Inking Agreement With Alkermes ↗
November 14, 2025
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
November 13, 2025
Via Benzinga
News headline image
Alkermes Eyes Global Phase 3 Trial After Encouraging Data From Sleep Disorder Study ↗
November 12, 2025
Via Benzinga
News headline image
This Alkermes Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday ↗
November 11, 2025
Via Benzinga
News headline image
ALKERMES PLC (NASDAQ:ALKS) Q3 2025 Earnings Beat Estimates and Drive Stock Surge ↗
October 28, 2025
Via Chartmill
Topics Earnings

Frequently Asked Questions

Is Alkermes plc - Ordinary Shares publicly traded?
Yes, Alkermes plc - Ordinary Shares is publicly traded.
What exchange does Alkermes plc - Ordinary Shares trade on?
Alkermes plc - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Alkermes plc - Ordinary Shares?
The ticker symbol for Alkermes plc - Ordinary Shares is ALKS on the Nasdaq Stock Market
What is the current price of Alkermes plc - Ordinary Shares?
The current price of Alkermes plc - Ordinary Shares is 28.35
When was Alkermes plc - Ordinary Shares last traded?
The last trade of Alkermes plc - Ordinary Shares was at 03/05/26 04:00 PM ET
What is the market capitalization of Alkermes plc - Ordinary Shares?
The market capitalization of Alkermes plc - Ordinary Shares is 4.71B
How many shares of Alkermes plc - Ordinary Shares are outstanding?
Alkermes plc - Ordinary Shares has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap